Posted in | News

PVS Enters Agreement for Construction of New Facility at PPG’s Natrium Plant

PPG Industries (NYSE:PPG) today announced that it has reached an agreement with PVS Technologies (PVS) regarding the construction of a PVS facility at PPG’s Natrium, W.Va., chlor-alkali and derivatives plant, where PVS will manufacture iron salts. The new plant is expected to begin operation in late 2010. Financial terms were not disclosed.

As part of the agreement, PVS will construct and operate the new plant, with a capacity to produce 50,000 tons of iron salts annually, including ferric chloride. PPG will supply chlorine, other raw materials and services from its Natrium plant to PVS for the new facility.

“This is another example of PPG’s commitment to and investment in the Natrium facility and our chlor-alkali and derivatives customers,” said Michael H. McGarry, PPG senior vice president, Commodity Chemicals. “We have secured a long-term chlorine customer in our own backyard, and we are pleased to welcome PVS to our Natrium site. We look forward to a successful collaboration.”

Dennis Rutkowski, president of PVS Technologies, said, “Our new facility at Natrium will significantly expand PVS’s total production capacity, as well our geographic reach and ability to serve new and existing customers in the United States.”

Commenting on the announcement, West Virginia Governor Joe Manchin said, "We welcome this new investment to Marshall County. New investments on available sites at chemical facilities, such as this, really help secure existing jobs and lay the foundation to expand industries and create new jobs. I applaud this joint partnership between PPG and PVS, and I am confident that this collaboration will benefit this region and our state."

Source: http://www.pvschemicals.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.